The Usage Of Government Formulary For BPJS Inpatients With Ischemic Stroke In Indonesia

Lukman Prayitno, Novita Novita, Sonya Esther, Erlina Puspitaloka Mahadewi
{"title":"The Usage Of Government Formulary For BPJS Inpatients With Ischemic Stroke In Indonesia","authors":"Lukman Prayitno, Novita Novita, Sonya Esther, Erlina Puspitaloka Mahadewi","doi":"10.51601/ijhp.v4i3.347","DOIUrl":null,"url":null,"abstract":"Introduction: Ischemic stroke patients tend to use some medicine. In National Health Security (JKN), the government has created a government formulary as quality control and cost control. The study aims to determine the percentage of government formulary in Hospitals and the affected factors. Method: It was cross sectional quantitative research. It used retrospective data from medical record and prescription of ischemic stroke inpatients from January to June 2019. The data collected include hospital characteristics, patient characteristics, supporting characteristics and treatment costs. Result: The data cames from 17 hospitals. Based on the inclusion and exclusion criteria, 257 medical records were analyzed. The average percentage of drug use was 73.22%. Its was influenced by the hospital class, the number of supporting examinations, the number of drug items. Type B and C hospitals used non government formulary. There were citicolin, mecobalamin, piracetam, neurotropic multivitamin, flunarizine. Conclusion: The average percentage of drug use was still less than 100%. There were still non government formulary drugs used for the therapy of inpatient ischemic stroke. The use of non government formulary drugs was influenced by the hospital class, the number of supporting examinations, the number of drug items.","PeriodicalId":432290,"journal":{"name":"International Journal of Health and Pharmaceutical (IJHP)","volume":"40 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Health and Pharmaceutical (IJHP)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.51601/ijhp.v4i3.347","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Ischemic stroke patients tend to use some medicine. In National Health Security (JKN), the government has created a government formulary as quality control and cost control. The study aims to determine the percentage of government formulary in Hospitals and the affected factors. Method: It was cross sectional quantitative research. It used retrospective data from medical record and prescription of ischemic stroke inpatients from January to June 2019. The data collected include hospital characteristics, patient characteristics, supporting characteristics and treatment costs. Result: The data cames from 17 hospitals. Based on the inclusion and exclusion criteria, 257 medical records were analyzed. The average percentage of drug use was 73.22%. Its was influenced by the hospital class, the number of supporting examinations, the number of drug items. Type B and C hospitals used non government formulary. There were citicolin, mecobalamin, piracetam, neurotropic multivitamin, flunarizine. Conclusion: The average percentage of drug use was still less than 100%. There were still non government formulary drugs used for the therapy of inpatient ischemic stroke. The use of non government formulary drugs was influenced by the hospital class, the number of supporting examinations, the number of drug items.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
印度尼西亚缺血性脑卒中 BPJS 住院患者对政府处方集的使用情况
导言缺血性中风患者往往会使用一些药物。在国家卫生安全(JKN)中,政府制定了政府处方集,以控制质量和成本。本研究旨在确定政府处方集在医院中所占的比例及其影响因素。研究方法这是一项横断面定量研究。研究使用了 2019 年 1 月至 6 月缺血性脑卒中住院患者的病历和处方的回顾性数据。收集的数据包括医院特征、患者特征、支持特征和治疗费用。研究结果数据来自 17 家医院。根据纳入和排除标准,分析了 257 份病历。平均用药比例为 73.22%。其受医院等级、辅助检查次数、药物项目数量的影响。B 类和 C 类医院使用的是非政府处方集。其中有枸橼酸、甲钴胺、吡拉西坦、神经性复合维生素、氟桂利嗪。结论平均用药比例仍低于 100%。在缺血性脑卒中住院患者的治疗中,仍有非处方药物的使用。非处方药物的使用受医院等级、辅助检查次数、药物项目数量的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Administration of Eucalyptus to Inhibit the Skin Aging Process of Rats (Rattus Norvegicus) Wistar Strains Exposed to Ultraviolet-B Light Effect of Celery (Apium graveolens L.) Extract Administration on Kidney Function of White Rats (Rattus norvegicus) Wistar Strains Exposed to Lead The Relationship Between Covid-19 Vaccination And The Incidence Of Covid-19 At The Hospital Putri Hijau Hospital, Medan The Usage Of Government Formulary For BPJS Inpatients With Ischemic Stroke In Indonesia Analysis Of Factors Related To The Cause Of Drug Withdrawal In Patients With Type Ii Diabetes Mellitus At Tk Ii Putri Hijau Kesdam 1/Bb Medan Hospital In 2020
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1